Medtronic (NYSE:MDT) has launched its MiniMed Mio Advance infusion sets, which are designed for people managing their diabetes with insulin pump therapy.
The medtech titan touted its product, which was developed by ConvaTec, as boasting a user-friendly design that allows patients to access hard-to-reach sites, like the lower back. The infusion system has no visible needle and features a built-in insertion device, according to Medtronic.
Get the full story at our sister site, Drug Delivery Business News.
The post Medtronic expands insulin pump portfolio with MiniMed Mio infusion set appeared first on MassDevice.
from MassDevice http://ift.tt/2BFtyh0
Cap comentari:
Publica un comentari a l'entrada